Literature DB >> 11496950

Protamine sulfate enhances the transduction efficiency of recombinant adeno-associated virus-mediated gene delivery.

Y W Yang1, Y C Hsieh.   

Abstract

PURPOSE: The purpose of this study was to evaluate glucose responsiveness in HepG2 human hepatoma cells transduced by a recombinant adeno-associated virus (rAAV) vector containing the insulin gene promoter. and to investigate the effect of protamine sulfate on rAAV-mediated gene delivery.
METHODS: Recombinant AAV vector, AAV.Ins.Luc.delta EGFP, was employed to transduce HepG2 hepatoma cells. Virus infection was carried out either in the absence or presence of protamine sulfate, followed by fluorescence microscopic examination, luciferase activity assay, and flow cytometric analysis. Electrokinetic measurements were carried out to determine the effect of protamine sulfate on zeta potential of the cells and the virus.
RESULTS: Glucose-responsive luciferase gene expression was obtained in rAAV-transduced HepG2 cells. Addition of 5 microg/ml protamine reversed the zeta potential of the cells and the virus particles, leading to enhanced transgene expression in rAAV-transduced HepG2 cells. Enhancement of protamine sulfate on rAAV-mediated gene transfer was dose-dependent. Addition of more than 5 microg/ml protamine resulted in a reduction of infectability of the virus.
CONCLUSIONS: Glucose responsiveness in the millimolar concentration range can be obtained in rAAV-transduced HepG2 cells. Protamine sulfate, up to 5 microg/ml, enhanced the rAAV transduction efficiency in HepG2 cells. The enhancement was correlated with zeta potential of the cells and the virus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496950     DOI: 10.1023/a:1010923924844

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Adeno-associated virus as a gene delivery vector for liver cells.

Authors:  J Y Lau
Journal:  J Hepatol       Date:  1999-08       Impact factor: 25.083

2.  Glucose responsiveness of a reporter gene transduced into hepatocytic cells using a retroviral vector.

Authors:  R Chen; B Doiron; A Kahn
Journal:  FEBS Lett       Date:  1995-05-29       Impact factor: 4.124

Review 3.  Insulin-dependent diabetes mellitus.

Authors:  R Tisch; H McDevitt
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

4.  Engineering of a glucose-responsive surrogate cell for insulin replacement therapy of experimental insulin-dependent diabetes.

Authors:  M Tiedge; M Elsner; N H McClenaghan; H J Hedrich; D Grube; J Klempnauer; S Lenzen
Journal:  Hum Gene Ther       Date:  2000-02-10       Impact factor: 5.695

5.  Glucose regulated production of human insulin in rat hepatocytes.

Authors:  P M Thulé; J Liu; L S Phillips
Journal:  Gene Ther       Date:  2000-02       Impact factor: 5.250

6.  High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors.

Authors:  J A Chiorini; C M Wendtner; E Urcelay; B Safer; M Hallek; R M Kotin
Journal:  Hum Gene Ther       Date:  1995-12       Impact factor: 5.695

7.  Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.

Authors:  G Podsakoff; K K Wong; S Chatterjee
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Regulatable production of insulin from primary-cultured hepatocytes: insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin.

Authors:  D Lu; H Tamemoto; H Shibata; I Saito; T Takeuchi
Journal:  Gene Ther       Date:  1998-07       Impact factor: 5.250

Review 9.  Adeno-associated virus vectors.

Authors:  B J Carter
Journal:  Curr Opin Biotechnol       Date:  1992-10       Impact factor: 9.740

10.  Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells.

Authors:  S Goodman; X Xiao; R E Donahue; A Moulton; J Miller; C Walsh; N S Young; R J Samulski; A W Nienhuis
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  10 in total

1.  Optimization of lentiviral transduction parameters and its application for CRISPR-based secretome modification of human endometrial mesenchymal stem cells.

Authors:  Pavel Deryabin; Anastasiia Griukova; Alla Shatrova; Alexey Petukhov; Nikolay Nikolsky; Aleksandra Borodkina
Journal:  Cell Cycle       Date:  2019-03-28       Impact factor: 4.534

2.  Glucose- and metabolically regulated hepatic insulin gene therapy for diabetes.

Authors:  Paul Yueh-Jen Hsu; Robert M Kotin; Ya-Wun Yang
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

3.  Adenovector-mediated gene delivery to human umbilical cord mesenchymal stromal cells induces inner ear cell phenotype.

Authors:  Keerthana Devarajan; M Laird Forrest; Michael S Detamore; Hinrich Staecker
Journal:  Cell Reprogram       Date:  2013-02       Impact factor: 1.987

4.  Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities.

Authors:  Paul Lin; Yuan Lin; Donald P Lennon; Diego Correa; Mark Schluchter; Arnold I Caplan
Journal:  Stem Cells Transl Med       Date:  2012-11-29       Impact factor: 6.940

5.  A new chemical complex can rapidly concentrate lentivirus and significantly enhance gene transduction.

Authors:  Jing-Yu Lee; Hu-Hui Lee
Journal:  Cytotechnology       Date:  2017-09-07       Impact factor: 2.058

6.  Glucose-modulated transgene expression via recombinant adeno-associated virus.

Authors:  Ya-Wun Yang; Yuan-Chiao Hsieh; Chih-Kai Chao
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

7.  Polymers for improving the in vivo transduction efficiency of AAV2 vectors.

Authors:  Gilles Moulay; Sylvie Boutin; Carole Masurier; Daniel Scherman; Antoine Kichler
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

8.  Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor.

Authors:  Ying Gong; Roel G J Klein Wolterink; Ian Janssen; Arjan J Groot; Gerard M J Bos; Wilfred T V Germeraad
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-29       Impact factor: 6.698

Review 9.  CAR-NK Cells: From Natural Basis to Design for Kill.

Authors:  Muhammad Babar Khawar; Haibo Sun
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

10.  Commentary: A Cost-Effective Method to Enhance Adenoviral Transduction of Primary Murine Osteoblasts and Bone Marrow Stromal Cells.

Authors:  Aikta Sharma; Alice Goring; Claire E Clarkin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-25       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.